Laurie Toich, Assistant Editor

The American College of Physicians testified in front of a Senate Subcommittee in support of the CREATES Act.

Newly approved IPF treatments can cost up to $98,000 annually.

The HHS recently proposed a 3-pronged strategy to deplete the backlog of Medicare appeals from 2015.

Solithera (solithromycin) treats community-acquired bacterial pneumonia.

Researchers were able to better predict the risk of developing breast cancer.

Top news of the day from across the healthcare landscape.

Certain neutrophils are able to detect a biomarker of cancer and other diseases.

Disabled workers have a higher rate of overdose-related death.

Naltrexone was found to stop cancer cell growth and promote apoptosis.

Mice without the LRH-1 protein develop less liver cancers than mice who had the protein.

Primary classes of early-stage bladder cancer have been discovered.

Approximately 58% of patients with nonalcoholic steatohepatitis treated with pioglitazone showed reduced disease activity.

Photodynamic therapy for skin cancer can cause immense burning pain to patients.

Research may lead to new treatments for ovarian cancer.

Driver mutations in lung adenocarcinoma and lung squamous cell carcinoma differ from one another, contradictory to previous theories.

Researchers examine how socialization institutes effect the way individuals in low income areas relate to HIV/AIDS after a natural disaster.

If cancerous tumors have an addiction to a gene, an inhibitor can be administered that can stop cell growth.

Elevated levels of RBFOX2 found in diabetic heart tissue could cause heart damage.

Postmenopausal patients with invasive ductal carcinomas had high levels of saturated fats.

A build-up of a metabolite found in urine could contribute to health problems faced by patients with kidney disease.

Medication targets the protein IL-33 that plays a role in asthma.

Blocking the chemokine CXCL1 resulted in slowed growth of obesity-related prostate cancer in mice models.

The peptide CAQK could potentially prevent damage to brain cells and blood vessels.

The drug eCF506 can selectively block the Src tyrosine kinase and stop the growth of breast cancer cells.

An antibody showed the ability to bind to the protein Bak and cause apoptosis.

Blocking the ERK1/2 pathway and the compensatory ERK5 pathway stopped the growth of colorectal tumors.

A novel test can detect Alzheimer's-related mild cognitive impairment with 100% accuracy.

The proposed payment model would reduce payments for high-cost specialty drugs.

Hacker announces plans to sell a copy of each database for $100,000 to $395,000.

Text-based health technologies shown to improve insurance rates among low income mothers.